CordovaCann (LVRLF) Operating Margin (2018 - 2019)
CordovaCann (LVRLF) recorded quarterly Operating Margin of 8179.19% in Q2 2019, up 151.63% quarter-over-quarter from 15842.29% in Q1 2019.
CordovaCann (LVRLF) Operating Margin (2018 - 2019) Analysis & Trends
CordovaCann's Operating Margin history runs 2 years deep, the most recent figure standing at 8179.19% for Q2 2019.
- In Q2 2019, Operating Margin changed N/A year-over-year to 8179.19%; the TTM figure through Jun 2019 stood at 1713568.99% (changed N/A YoY), while the FY2025 annual figure was 1.44%, up 321.0% from the prior year.
- Operating Margin was 8179.19% for Q2 2019 at CordovaCann, up from 15842.29% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 40057.78% in Q1 2018 to a low of 20494.89% in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 8,179.19% |
| Mar 31, 2019 | -15,842.29% |
| Dec 31, 2018 | -20,494.89% |
| Sep 30, 2018 | -11,842.51% |
| Mar 31, 2018 | 40,057.78% |